Identification of PTGS2 as a genetically supported protective biomarker and potential therapeutic target in myasthenia gravis
{{output}}
Background: Myasthenia Gravis (MG) is an autoimmune disease that damages the neuromuscular junction (NMJ), reduces the transmission of nerve impulses to muscles, and thus causes fluctuating muscle weakness and fatigue. The main t... ...
